(Reuters) - Latvian government health agencies on Tuesday announced a "temporary suspension" of up to two weeks of the use of AstraZeneca's COVID-19 vaccine in the country.
The move is "an additional precaution" while the vaccine is scrutinized, and no problems have been linked to its use in Latvia, the agencies said in a statement.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!